ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"
By
ecancer
FEATURING
Brian Van Tine
By
ecancer
FEATURING
Brian Van Tine
Comments 0
Login to view comments.
Click here to Login
